ELOPAK ASA financials
ELOPAK ASA
529900BIDQN2AOKV6N08 ISIN: NO0011002586 | Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | €1.16B | €1.13B |
| Other income | €89.0K | €145.0K |
| Operating expenses | €1.06B | €1.03B |
| Employee benefits expense | €203.2M | €189.6M |
| Raw materials & consumables used | €719.8M | €719.8M |
| Depreciation & amortisation | €64.4M | €60.1M |
| Operating profit (EBIT) | €99.5M | €102.8M |
| Net finance income / (cost) | -€20.4M | -€24.8M |
| Finance costs | €38.6M | €26.5M |
| Profit before tax | €89.4M | €83.5M |
| Income tax expense | €27.2M | €15.5M |
| Profit for the year | €62.2M | €68.0M |
| — attributable to owners | €60.9M | €67.1M |
| — attributable to NCI | €1.2M | €966.0K |
| Total comprehensive income | €71.2M | €66.4M |
| Per share | ||
| Basic EPS | €0.23 | €0.25 |
| Diluted EPS | €0.23 | €0.25 |
| Free cash flow / share | €0.11 | €0.42 |
| Cash flow statement | ||
| Net cash from operating activities | €139.9M | €155.1M |
| Income taxes paid | €27.3M | €14.3M |
| Net cash from investing activities | -€97.5M | -€32.0M |
| Net cash from financing activities | -€30.2M | -€135.3M |
| Dividends paid | €34.4M | €19.6M |
| Proceeds from borrowings | €291.8M | €1.09B |
| Repayments of borrowings | €246.2M | €1.17B |
| Lease liability payments | €23.6M | €18.4M |
| Balance sheet | ||
| Total assets | €1.06B | €962.6M |
| Non-current assets | €590.7M | €533.1M |
| Property, plant & equipment | €265.0M | €202.9M |
| Right-of-use assets | €92.0M | €86.4M |
| Intangible assets & goodwill | €107.6M | €106.1M |
| Current assets | €464.7M | €429.5M |
| Inventories | €197.9M | €192.2M |
| Trade & other receivables | €120.2M | €110.2M |
| Cash & equivalents | €28.1M | €13.3M |
| Total equity | €352.7M | €315.3M |
| — attributable to owners | €342.1M | €306.3M |
| Non-controlling interests | €10.6M | €9.0M |
| Non-current liabilities | €369.0M | €324.4M |
| Long-term borrowings | €259.7M | €224.4M |
| Lease liabilities (non-current) | €83.2M | €78.4M |
| Current liabilities | €333.8M | €322.9M |
| Lease liabilities (current) | €23.3M | €23.1M |
| Deferred tax liabilities | €14.6M | €14.0M |
| Derived metrics | ||
| Free cash flow | €30.8M | €114.3M |
| Operating margin | 8.6% | 9.1% |
| Net margin | 5.4% | 6.0% |
| Return on equity | 17.6% | 21.6% |
| Cash conversion ratio | 2.25× | 2.28× |
| Capex coverage | 1.28× | 3.80× |
| Other reported items | ||
| Additional Paidin Capital | €71.7M | €70.5M |
| Adjustments For Decrease Increase In Inventories | -€752.0K | -€7.0M |
| Adjustments For Decrease Increase In Other Current Assets | €79.0K | -€5.3M |
| Adjustments For Decrease Increase In Trade Account Receivable | -€7.0M | -€9.3M |
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €66.9M | €61.3M |
| Adjustments For Increase Decrease In Employee Benefit Liabilities | -€148.0K | -€228.0K |
| Adjustments For Increase Decrease In Other Current Liabilities | €23.8M | €25.0M |
| Adjustments For Increase Decrease In Trade Account Payable | -€15.8M | €1.8M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | €56.0K | -€13.0K |
| Adjustments For Unrealised Foreign Exchange Losses Gains | -€4.6M | -€174.0K |
| Basic Earnings Loss Per Share From Continuing Operations | €0.22 | €0.25 |
| Basic Earnings Loss Per Share From Discontinued Operations | €0.00 | €0.00 |
| Cash Flows From Losing Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €2.0M | €4.9M |
| Comprehensive Income Attributable To Noncontrolling Interests | €1.6M | €583.0K |
| Comprehensive Income Attributable To Owners of Parent | €69.7M | €65.8M |
| Current Borrowings and Current Portion of Noncurrent Borrowings | €30.4M | €19.3M |
| Current Payables On Social Security and Taxes Other Than Income Tax | €26.0M | €25.1M |
| Current Tax Liabilities Current | €5.3M | €7.0M |
| Deferred Tax Assets | €22.3M | €22.9M |
| Diluted Earnings Loss Per Share From Continuing Operations | €0.22 | €0.25 |
| Diluted Earnings Loss Per Share From Discontinued Operations | €0.00 | €0.00 |
| Dividends Paid To Equity Holders of Parent Classified As Financing Activities | €34.4M | €19.6M |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | €0.13 | — |
| Dividends Received From Joint Ventures Classified As Investing Activities | €9.9M | €2.0M |
| Dividends Recognised As Distributions To Owners Per Share | €1.46 | — |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | €2.5M | -€310.0K |
| Equity and Liabilities | €1.06B | €962.6M |
| Finance Income | €18.3M | €7.8M |
| Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss | €6.8M | -€498.0K |
| Gains Losses Recognised In Profit Or Loss Fair Value Measurement Assets | -€6.9M | -€5.5M |
| Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €2.6M | €1.2M |
| Increase Decrease In Cash and Cash Equivalents | €14.7M | -€12.6M |
| Increase Decrease Through Sharebased Payment Transactions | €780.0K | €1.1M |
| Increase Decrease Through Transactions With Owners | -€33.9M | -€19.1M |
| Increase Decrease Through Treasury Share Transactions | -€243.0K | -€589.0K |
| Intangible Assets Other Than Goodwill | €52.9M | €62.3M |
| Investments In Joint Ventures | €37.8M | €37.7M |
| Issued Capital | €50.1M | €50.1M |
| Liabilities | €702.8M | €647.3M |
| Noncurrent Recognised Liabilities Defined Benefit Plan | €2.2M | €2.5M |
| Other Comprehensive Income | €9.1M | -€1.6M |
| Other Comprehensive Income Net of Tax Cash Flow Hedges | €973.0K | -€1.5M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | €171.0K | -€81.0K |
| Other Current Assets | €118.5M | €113.7M |
| Other Current Liabilities | €135.8M | €120.5M |
| Other Current Payables | €39.8M | €40.5M |
| Other Expense By Nature | €67.2M | €58.7M |
| Other Noncurrent Assets | €13.1M | €14.9M |
| Other Noncurrent Liabilities | €9.2M | €5.0M |
| Payments To Acquire Or Redeem Entitys Shares | €1.8M | €885.0K |
| Proceeds From Disposals of Property Plant and Equipment Intangible Assets Other Than Goodwill Investment Property and Other Noncurrent Assets | €0 | €122.0K |
| Profit Loss From Continuing Operations | €61.5M | €69.4M |
| Profit Loss From Discontinued Operations | €603.0K | -€1.3M |
| Purchase of Property Plant and Equipment Intangible Assets Other Than Goodwill Investment Property and Other Noncurrent Assets | €109.1M | €40.8M |
| Reserve of Cash Flow Hedges | -€3.3M | -€4.3M |
| Reserve of Exchange Differences On Translation | -€19.5M | -€27.1M |
| Retained Earnings | €243.0M | €217.0M |
| Revenue and Operating Income | €1.16B | €1.13B |
| Share of Profit Loss of Joint Ventures Accounted For Using Equity Method | €9.7M | €6.9M |
| Trade and Other Current Payables To Trade Suppliers | €73.3M | €87.4M |
Every line item above is a fact tagged in ELOPAK ASA's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.